RSNA: Toshiba focuses on modality portfolio

Toshiba America Medical Systems highlighted its ultrasound technology, spot fluoroscopy, wireless digital radiography (DR) and CT system at the annual meeting of the Radiological Society of North America (RSNA).

Toshiba showcased tools for the Aplio 500 and Aplio 300 ultrasound systems, including UltraExtend FX Workstation. The recently FDA-cleared workstation is designed for radiology applications, including Aplio 500’s Fly Thru. Luminance, a works-in-progress, is a 4D rendering and lighting technique. Other ultrasound works-in progress included new transducers--an endocavitary transducer and small parts transducer.

The Tustin, Calif.-based company introduced Spot Fluoroscopy for its Infinix-i cardiovascular x-ray systems, which allows clinicians to observe a target region of anatomy using Spot Fluoro’s live fluoroscopy while viewing the Last Image Hold surrounding area.

The RADREX-i Wireless DR system provides automated RexSpeed features, RexView with image preview from the original RADREX-I and a cableless 14-inch x17-inch panel. The system can be positioned close to the anatomy for out-of-bucky work, Toshiba said.

Toshiba also unveiled the Aquilion One ViSION Edition CT scanner, which is equipped with a gantry rotation of 0.275 seconds, a 100 kw generator and 320 detector rows covering 16 cm in a single rotation, with 500 micron slices. The 78 cm-bore system can accommodate bariatric patients and patients with high heart rates, Toshiba said. Aquilion One ViSION Edition also includes Toshiba’s iterative dose reconstruction software, AIDR 3D.

Toshiba launched PROTECT, a three-year CT radiation dose management program to help customers achieve ALARA (as low as reasonably achievable) imaging with Toshiba’s Aquilion CT product line. PROTECT provides in-person collaboration to review the system’s hardware and software and consider implementation of additional dose reduction technologies.

              

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.